Other Comprehensive Income (Loss) (Tables)

12 Months Ended

Dec. 31, 2021

Components of Accumulated Other Comprehensive Loss, Net of Tax

The table below sets forth the components of accumulated other comprehensive income (loss), net of tax for the years ended December 31, 2021, 2020, and 2019.


	Foreign Currency Translation		Available-for- Sale Investments		Cash Flow Hedges (1)		Total
Balance as of December 31, 2018	$	(665)	$	16,584	$	576	$	16,495
Foreign currency translation adjustment, net of tax of $0	99		—		—		99
Unrealized gain (loss) on investments:
Change in fair value, net of tax of $185	—		(702)		—		(702)
Unrealized gain (loss) on cash flow hedges:
Change in fair value, net of tax of $295	—		—		(819)		(819)
Reclassification adjustment into earnings, net of tax of $48	—		—		(137)		(137)
Balance as of December 31, 2019	(566)		15,882		(380)		14,936
Foreign currency translation adjustment, net of tax of $0	348		—		—		348
Unrealized gain (loss) on investments:
Change in fair value, net of tax of $(499)	—		1,323		—		1,323
Unrealized gain (loss) on cash flow hedges:
Change in fair value, net of tax of $1,693	—		—		(4,652)		(4,652)
Reclassification adjustment into earnings, net of tax of $(388)	—		—		1,106		1,106
Balance as of December 31, 2020	(218)		17,205		(3,926)		13,061
Foreign currency translation adjustment, net of tax of $0	157		—		—		157
Reclassification adjustments into earnings, net of tax of $0(2)	(1,082)		—		—		(1,082)
Unrealized gain (loss) on investments:
Change in fair value, net of tax of $(385)	—		1,169		—		1,169
Unrealized gain (loss) on cash flow hedges:
Change in fair value, net of tax of $(641)	—		—		1,606		1,606
Reclassification adjustment into earnings, net of tax of $(678)	—		—		1,929		1,929
Balance as of December 31, 2021	$	(1,143)	$	18,374	$	(391)	$	16,840

(1) The before tax amounts reclassified from accumulated other comprehensive income (loss) related to our cash flow hedges are recorded to interest expense, net of interest income.

(2) In connection with the divestiture of the Life Sciences business, which included a substantially complete liquidation of an investment within a foreign entity, we included $1.1 million of accumulated translation gains in the calculation of our gain on sale recorded within other income, net on our consolidated statement of operations. See Note 3 "Acquisitions and Divestitures" for additional information on the divestiture of the Life Sciences business in 2021.